author-photo

Hideyuki Mishima

Aichi Medical University

88

Papers

871

Citations

Citation Trend

Filter By

Papers (66) Sort By

Journal Conference Others

Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS study).

2020 Oncologist
Show All
- Source
- Cite
- Save
Citations (8)
Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naive older or frail patients with metastatic colorectal cancer (OGSG 0802).

2020 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
P-37 phase II study of oxaliplatin-based regimen in relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: INSPIRE study

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study

2019 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (11)
Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
571PRandomized phase III study of sequential treatment with capecitabine or 5-fluorouracil (FP) plus bevacizumab (BEV) followed by the addition with oxaliplatin (OX) versus initial combination with OX+FP+ BEV in the first-line chemotherapy for metastatic colorectal cancer: The C-cubed study

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

2019 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (8)
Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin‑based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials

2019 Oncology Letters
Show All
- Source
- Cite
- Save
Citations (1)
Effects of Dietary Instructions Including Meal-Sequence for Prediabetes Subjects—Comparison with Conventional Approach

2018 Diabetes
Show All
- Source
- Cite
- Save
Citations (1)
A multicenter single‑arm Phase II clinical trial of second‑line FOLFIRI plus panitumumab after first‑line treatment with FOLFOX plus panitumumab for initial RAS wild‑type colorectal cancer with evaluation of circulating tumor DNA: A protocol study

2018 Oncology Letters
Show All
- Source
- Cite
- Save
Citations (2)